[1] NCD RISK FACTOR COLLABORATION (NCD-RISC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-2642.
[2] LEE EY, YOON KH. Epidemic obesity in children and adolescents: risk factors and prevention. Front Med. 2018;12(6):658-666.
[3] ZHANG X, ZHANG M, ZHAO Z, et al. Geographic variation in prevalence of adult obesity in China: Results from the 2013-2014 National Chronic Disease and Risk Factor Surveillance. Ann Intern Med. 2020;172(4):291-293.
[4] LUO NY. Establishment and Issue of Healthy China Action Committee (2019-2030). Zhongyiyao Guanli Zazhi. 2019;27(14):cover 2.
[5] WILLIAMS R, AITHAL G, ALEXANDER GJ, et al. Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK. Lancet. 2020;395(10219):226-239.
[6] GBD 2015 OBESITY COLLABORATORS, AFSHIN A, FOROUZANFAR MH, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13-27.
[7] MOORADIAN AD. In search for an alternative to sugar to reduce obesity. Int J Vitam Nutr Res. 2019;89(3-4):113-117.
[8] HUI S, COWAN AJ, ZENG X, et al. Quantitative fluxomics of circulating metabolites. Cell Metab. 2020;32(4):676-688.e4.
[9] GOMEZ-ARBELAEZ D, CRUJEIRAS AB, CASTRO AI, et al. Acid-base safety during the course of a very low-calorie-ketogenic diet. Endocrine. 2017;58(1):81-90.
[10] GIANNOUDAKI E, HERNANDEZ-SANTANA YE, MULFAUL K, et al. Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction. Nat Commun. 2019;10(1):4003.
[11] FORTE N, FERNÁNDEZ-RILO AC, PALOMBA L, et al. Obesity affects the microbiota-gut-brain axis and the regulation thereof by endocannabinoids and related mediators. Int J Mol Sci. 2020;21(5):1554.
[12] BLÜHER M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019; 15(5):288-298.
[13] TODA G, SOEDA K, OKAZAKI Y, et al. Insulin- and lipopolysaccharide-mediated signaling in adipose tissue macrophages regulates postprandial glycemia through Akt-mTOR activation. Mol Cell. 2020;79(1):43-53.e4.
[14] GUO ZP. Quantitative medical imaging evaluation of fatty liver. Zhonghua Jiankang Guanglixue Zazhi. 2020;14(6):583-586.
[15] XIA MF, BIAN H, GAO X. Thoughts on the change of nomenclature from non-alcoholic fatty liver disease to metabolic associated fatty liver disease. Zhonghua Tangniaobing Zazhi. 2020;12(7):445-450.
[16] SONG XG, HE YB. Advances in the application of magnetic resonance imaging in hepatic fat quantification in patients with nonalcoholic fatty liver disease. Chin Hepatol. 2020;25(5):536-538.
[17] D’SOUZA MS, DONG TA, RAGAZZO G, et al. From fad to fact: evaluating the impact of emerging diets on the prevention of cardiovascular disease. Am J Med. 2020; 133(10):1126-1134.
[18] SARTORIUS K, SARTORIUS B, MADIBA TE, et al. Does high-carbohydrate intake lead to increased risk of obesity? A systematic review and meta-analysis. BMJ Open. 2018; 8(2):e018449.
[19] LYONS L, SCHOELER NE, LANGAN D, et al. Use of ketogenic diet therapy in infants with epilepsy: a systematic review and meta-analysis. Epilepsia. 2020;61(6):1261-1281.
[20] GUO YL, RUAN LT, DANG Y, et al. Application value of liver and spleen stiffness measured by real-time shear wave elastography combined with hepatic steatosis index in diagnosis of hepatic steatosis. Journal of China Clinic Medical Imaging. 2019;30(6):416-420.
[21] SHI HP, YU KY, ZHOU H. Low carbon diet, cancer metabolism and nutrition. Electronic J. 2019;6(1):1-6.
[22] WAISE TMZ, RASTI M, DUCA FA, et al. Inhibition of upper small intestinal mTOR lowers plasma glucose levels by inhibiting glucose production. Nat Commun. 2019;10(1):714.
[23] RASTELLI M, CANI PD, KNAUF C. The gut microbiome influences host endocrine functions. Endocr Rev. 2019;40(5):1271-1284.
[24] VISCONTI A, LE ROY CI, ROSA F, et al. Interplay between the human gut microbiome and host metabolism. Nat Commun. 2019;10(1):4505.
[25] GUAZZELLI MARQUES C, DE PIANO GANEN A, ZACCARO DE BARROS A, et al. Weight loss probiotic supplementation effect in overweight and obesity subjects: a review. Clin Nutr. 2020; 39(3):694-704.
[26] LI S, QI C, ZHU H, et al. Lactobacillus reuteri improves gut barrier function and affects diurnal variation of the gut microbiota in mice fed a high-fat diet. Food Funct. 2019;10(8): 4705-4715.
[27] ZUO K, LI J, XU Q, et al. Dysbiotic gut microbes may contribute to hypertension by limiting vitamin D production. Clin Cardiol. 2019;42(8): 710-719.
[28] WU T, SUN M, LIU R, et al. Bifidobacterium longum subsp. longum remodeled roseburia and phosphatidylserine levels and ameliorated intestinal disorders and liver metabolic abnormalities induced by high-fat diet. J Agric Food Chem. 2020;68(16):4632-4640.
[29] MARTENS EC, NEUMANN M, DESAI MS. Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat Rev Microbiol. 2018;16(8):457-470.
[30] VIRTUE AT, MCCRIGHT SJ, WRIGHT JM, et al. The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs. Sci Transl Med. 2019; 11(496):eaav1892.
[31] LIU JG, LIN XP, ZHANG Y, et al. Analysis of the effects and mechanism of compound intestinal microecological preparation combined with modified low-carbon diet on appetite and body fat metabolism in children with simple obesity. Chin Gen Prac. 2020;23(29):3675-3681.
|